Surgical excision of loco-regionally recurrent head and neck cancers is associated with a median disease free survival of 17.9months [1]. The utility of surgical excision is limited to stage I–II patients; only very few of recurrent head and neck cancer patients can undergo resection [2]. When surgical salvage is not possible, re-irradiation is the next option. However, patients with locally advanced technically unresectable disease (T4a and T4b) are unlikely to be candidates for re-irradiation.
from #ENT via xlomafota13 on Inoreader http://ift.tt/1TlXAJ3
via IFTTT
Πέμπτη 31 Μαρτίου 2016
Technically unresectable recurrent oral cancers: Is NACT the answer?
Αναρτήθηκε από
Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182
στις
5:10 μ.μ.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου